Increasing access to erectile dysfunction treatment via pharmacies to improve healthcare provider visits and quality of life: Results from a prospective real‐world observational study in the United Kingdom

OBJECTIVES: The Medicines and Healthcare Products Regulatory Agency in the United Kingdom (UK) formally reclassified sildenafil citrate 50 mg tablets as a pharmacy medicine (sildenafil‐P) in 2017 for adult men with erectile dysfunction (ED). A 1‐year prospective real‐world observational study was co...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Int J Clin Pract
Autori principali: Lee, Lauren J., Maguire, Terence A., Maculaitis, Martine C., Emir, Birol, Li, Vicky W., Jeffress, Mara, Li, Jim Z., Zou, Kelly H., Donde, Shaantanu S., Taylor, David
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2020
Soggetti:
Original Papers
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8047876/
https://ncbi.nlm.nih.gov/pubmed/33220087
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ijcp.13849
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi